FDA to Sunset Alternative Summary Reporting (ASR) Program
The FDA has announced an end to the alternative summary reporting (ASR) program [...]
The FDA has announced an end to the alternative summary reporting (ASR) program [...]
FDA regulation 21 part 822 lays out the process, the rules, and the products tha [...]
Risk management and adverse event reporting protocols for medical device manufac [...]